These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 31298489

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H.
    Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Do COVID-19 Infections Result in a Different Form of Secondary Hemophagocytic Lymphohistiocytosis.
    Chu R, van Eeden C, Suresh S, Sligl WI, Osman M, Cohen Tervaert JW.
    Int J Mol Sci; 2021 Mar 15; 22(6):. PubMed ID: 33803997
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study.
    Su L, Feng L, Liu C, Jiang Z, Li M, Xiao K, Yan P, Jia Y, Feng D, Xie L.
    BMC Nephrol; 2012 Sep 26; 13():123. PubMed ID: 23013330
    [Abstract] [Full Text] [Related]

  • 28. Utility of Macrophage-activated Marker CD163 for Diagnosis and Prognosis in Pulmonary Tuberculosis.
    Suzuki Y, Shirai M, Asada K, Miwa S, Karayama M, Nakamura Y, Inui N, Shirai T, Hayakawa H, Baba S, Suda T.
    Ann Am Thorac Soc; 2017 Jan 26; 14(1):57-64. PubMed ID: 27684274
    [Abstract] [Full Text] [Related]

  • 29. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 26; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 30. Study of the diagnostic criteria for hemophagocytic lymphohistiocytosis in neonatal and pediatric patients with severe sepsis or septic shock.
    Elalfy MS, Ragab IA, AbdelAal NM, Mahfouz S, Rezk AR.
    Pediatr Hematol Oncol; 2021 Aug 26; 38(5):486-496. PubMed ID: 33622175
    [Abstract] [Full Text] [Related]

  • 31. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun 26; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 32. Differential expression and predictive value of monocyte scavenger receptor CD163 in populations with different tuberculosis infection statuses.
    Liu Q, Ou Q, Chen H, Gao Y, Liu Y, Xu Y, Ruan Q, Zhang W, Shao L.
    BMC Infect Dis; 2019 Nov 28; 19(1):1006. PubMed ID: 31779590
    [Abstract] [Full Text] [Related]

  • 33. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.
    PLoS One; 2015 Nov 28; 10(4):e0119681. PubMed ID: 25860354
    [Abstract] [Full Text] [Related]

  • 34. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.
    Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926
    [Abstract] [Full Text] [Related]

  • 35. Hemophagocytic lymphohistiocytosis in critically ill patients: diagnostic reliability of HLH-2004 criteria and HScore.
    Knaak C, Nyvlt P, Schuster FS, Spies C, Heeren P, Schenk T, Balzer F, La Rosée P, Janka G, Brunkhorst FM, Keh D, Lachmann G.
    Crit Care; 2020 May 24; 24(1):244. PubMed ID: 32448380
    [Abstract] [Full Text] [Related]

  • 36. [Changes and significance of soluble CD 163 in sepsis and severe sepsis in children].
    Cui Y, Zhang YC, Rong QF, Zhu Y.
    Zhonghua Er Ke Za Zhi; 2012 Sep 24; 50(9):653-6. PubMed ID: 23158813
    [Abstract] [Full Text] [Related]

  • 37. Circulating levels of the shed scavenger receptor sCD163 and association with outcome of critically ill patients.
    Ingels C, Møller HJ, Hansen TK, Wouters PJ, Vanhorebeek I, Van den Berghe G.
    J Clin Immunol; 2013 Apr 24; 33(3):619-29. PubMed ID: 23150181
    [Abstract] [Full Text] [Related]

  • 38. Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma.
    Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA, Gottlieb D, Ritchie D, Gill D, Gandhi MK.
    Clin Cancer Res; 2013 Feb 01; 19(3):731-42. PubMed ID: 23224400
    [Abstract] [Full Text] [Related]

  • 39. Hemophagocytic lymphohistiocytosis mimicking surgical symptoms and complications: lessons learned from four cases.
    Siminas S, Caswell M, Kenny SE.
    J Pediatr Surg; 2013 Jul 01; 48(7):1514-9. PubMed ID: 23895965
    [Abstract] [Full Text] [Related]

  • 40. Macrophage serum markers in pneumococcal bacteremia: Prediction of survival by soluble CD163.
    Møller HJ, Moestrup SK, Weis N, Wejse C, Nielsen H, Pedersen SS, Attermann J, Nexø E, Kronborg G.
    Crit Care Med; 2006 Oct 01; 34(10):2561-6. PubMed ID: 16915112
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.